Osang Healthcare Co., Ltd. (Osang LLC)

Osang Healthcare is a South Korean diagnostic manufacturer with 25+ years of global experience operating in 110+ countries. The company specializes in rapid infectious disease testing and point-of-care diagnostics for healthcare providers, laboratories, and community settings. Core product portfolio includes COVID-19 and flu antigen rapid tests, COVID-19 PCR testing solutions, and point-of-care blood glucose monitors for human and veterinary use. The company has deployed over 20 million COVID-19 PCR tests across 70+ countries and supplied 130 million rapid antigen tests in the US market. Osang holds FDA Emergency Use Authorization (EUA) credentials and was the first South Korean company to receive FDA authorization for SARS-CoV-2 test kits. Quality certifications include ISO 9001, ISO 13485, TÜV SÜD, and MDSAP compliance. Manufacturing operations include GMP-certified facilities in Korea. The US subsidiary, Osang LLC, is based in South Pasadena, California, providing dedicated account management, logistics support, and technical assistance for healthcare partners nationwide. The company markets solutions for rapid turnaround, scalable deployment, and reliability in clinical and emergency settings.